167 related articles for article (PubMed ID: 31717859)
1. Role of L-Type Amino Acid Transporter 1 (LAT1) for the Selective Cytotoxicity of Sesamol in Human Melanoma Cells.
Srisongkram T; Weerapreeyakul N; Kärkkäinen J; Rautio J
Molecules; 2019 Oct; 24(21):. PubMed ID: 31717859
[TBL] [Abstract][Full Text] [Related]
2. Development of Sesamol Carbamate-L-Phenylalanine Prodrug Targeting L-Type Amino Acid Transporter1 (LAT1) as a Potential Antiproliferative Agent against Melanoma.
Srisongkram T; Bahrami K; Järvinen J; Timonen J; Rautio J; Weerapreeyakul N
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955600
[TBL] [Abstract][Full Text] [Related]
3. Route of intracellular uptake and cytotoxicity of sesamol, sesamin, and sesamolin in human melanoma SK-MEL-2 cells.
Srisongkram T; Weerapreeyakul N
Biomed Pharmacother; 2022 Feb; 146():112528. PubMed ID: 34906777
[TBL] [Abstract][Full Text] [Related]
4. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
Wiriyasermkul P; Nagamori S; Tominaga H; Oriuchi N; Kaira K; Nakao H; Kitashoji T; Ohgaki R; Tanaka H; Endou H; Endo K; Sakurai H; Kanai Y
J Nucl Med; 2012 Aug; 53(8):1253-61. PubMed ID: 22743251
[TBL] [Abstract][Full Text] [Related]
5. A new treatment for human malignant melanoma targeting L-type amino acid transporter 1 (LAT1): a pilot study in a canine model.
Fukumoto S; Hanazono K; Fu DR; Endo Y; Kadosawa T; Iwano H; Uchide T
Biochem Biophys Res Commun; 2013 Sep; 439(1):103-8. PubMed ID: 23954667
[TBL] [Abstract][Full Text] [Related]
6. Transport of Pregabalin Via L-Type Amino Acid Transporter 1 (SLC7A5) in Human Brain Capillary Endothelial Cell Line.
Takahashi Y; Nishimura T; Higuchi K; Noguchi S; Tega Y; Kurosawa T; Deguchi Y; Tomi M
Pharm Res; 2018 Oct; 35(12):246. PubMed ID: 30374619
[TBL] [Abstract][Full Text] [Related]
7. Validation of Cell-Based Assay for Quantification of Sesamol Uptake and Its Application for Measuring Target Exposure.
Srisongkram T; Weerapreeyakul N
Molecules; 2019 Sep; 24(19):. PubMed ID: 31569436
[TBL] [Abstract][Full Text] [Related]
8. Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human amino acid transporter LAT1 or LAT2 and delineation of their differential interaction with α-alkyl moieties.
Khunweeraphong N; Nagamori S; Wiriyasermkul P; Nishinaka Y; Wongthai P; Ohgaki R; Tanaka H; Tominaga H; Sakurai H; Kanai Y
J Pharmacol Sci; 2012; 119(4):368-80. PubMed ID: 22850614
[TBL] [Abstract][Full Text] [Related]
9. Involvement of LAT1 and LAT2 in the high- and low-affinity transport of L-leucine in human retinal pigment epithelial cells (ARPE-19 cells).
Yamamoto A; Akanuma S; Tachikawa M; Hosoya K
J Pharm Sci; 2010 May; 99(5):2475-82. PubMed ID: 19890975
[TBL] [Abstract][Full Text] [Related]
10. Structural properties for selective and efficient l-type amino acid transporter 1 (LAT1) mediated cellular uptake.
Kärkkäinen J; Gynther M; Kokkola T; Petsalo A; Auriola S; Lahtela-Kakkonen M; Laine K; Rautio J; Huttunen KM
Int J Pharm; 2018 Jun; 544(1):91-99. PubMed ID: 29669256
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of system L amino acid transporter subtypes in rat placenta and yolk sac.
Owaydhah WH; Ashton N; Verrey F; Glazier JD
Placenta; 2021 Jan; 103():188-198. PubMed ID: 33160252
[TBL] [Abstract][Full Text] [Related]
12. Sesamol induced apoptotic effect in lung adenocarcinoma cells through both intrinsic and extrinsic pathways.
Siriwarin B; Weerapreeyakul N
Chem Biol Interact; 2016 Jul; 254():109-16. PubMed ID: 27270451
[TBL] [Abstract][Full Text] [Related]
13. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells.
Kim SG; Kim HH; Kim HK; Kim CH; Chun HS; Kanai Y; Endou H; Kim DK
Anticancer Res; 2006; 26(3A):1989-96. PubMed ID: 16827134
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of mammalian cell lines stably expressing human L-type amino acid transporters.
Morimoto E; Kanai Y; Kim DK; Chairoungdua A; Choi HW; Wempe MF; Anzai N; Endou H
J Pharmacol Sci; 2008 Dec; 108(4):505-16. PubMed ID: 19075510
[TBL] [Abstract][Full Text] [Related]
15. Unique and selective expression of L-amino acid transporter 1 in human tissue as well as being an aspect of oncofetal protein.
Nakada N; Mikami T; Hana K; Ichinoe M; Yanagisawa N; Yoshida T; Endou H; Okayasu I
Histol Histopathol; 2014 Feb; 29(2):217-27. PubMed ID: 23824658
[TBL] [Abstract][Full Text] [Related]
16. Expression of large neutral amino acid transporters LAT1 and LAT2 in medulloblastoma.
Cicone F; Minniti G; Oliva MA; Carideo L; Prior JO; Scopinaro F; Giangaspero F; Arcella A
Brain Tumor Pathol; 2017 Oct; 34(4):179-181. PubMed ID: 28815339
[No Abstract] [Full Text] [Related]
17. Application of FTIR microspectroscopy for characterization of biomolecular changes in human melanoma cells treated by sesamol and kojic acid.
Srisayam M; Weerapreeyakul N; Barusrux S; Tanthanuch W; Thumanu K
J Dermatol Sci; 2014 Mar; 73(3):241-50. PubMed ID: 24296160
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
Kim DK; Kanai Y; Choi HW; Tangtrongsup S; Chairoungdua A; Babu E; Tachampa K; Anzai N; Iribe Y; Endou H
Biochim Biophys Acta; 2002 Sep; 1565(1):112-21. PubMed ID: 12225859
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of renal LAT1 and LAT2 and enhanced L-DOPA uptake in SHR immortalized renal proximal tubular cells.
Pinho MJ; Serrão MP; Gomes P; Hopfer U; Jose PA; Soares-da-Silva P
Kidney Int; 2004 Jul; 66(1):216-26. PubMed ID: 15200428
[TBL] [Abstract][Full Text] [Related]
20. The RNA interference of amino acid transporter LAT1 inhibits the growth of KB human oral cancer cells.
Kim CH; Park KJ; Park JR; Kanai Y; Endou H; Park JC; Kim DK
Anticancer Res; 2006; 26(4B):2943-8. PubMed ID: 16886618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
